Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions.

Drugs - 1 Jul 2021

Lin Eric Y, Adamson Paul C, Klausner Jeffrey D

Abstract excerpt

Neisseria gonorrhoeae is the second most common bacterial sexually transmitted infection in the world after Chlamydia trachomatis. The pathogen has developed resistance to every antibiotic currently approved for treatment, and multidrug-resistant strains have been identified globally. The current treatment recommended by the World Health Organization is ceftriaxone and azithromycin dual therapy. However,...

Topics

Join the communities discussing this publication.

Azithromycin
Bacterial Vaccines
Ceftriaxone
Clinical Trials as Topic
Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Neisseria gonorrhoeae

Practice Guidelines as Topic

Source

Open in PubMed Open full text

Identifiers

PMID: 34097283
DOI: 10.1007/s40265-021-01530-0
PMCID: PMC8182353

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions.PMID 34097283Read ↗

<em>Neisseria gonorrhoeae</em> in the Era of Antimicrobial Resistance: From Curable STI to Clinical ChallengeSemantic proximity Read ↗

[Unveiling Neisseria gonorrhoeae Survival: Genetic Variability, Pathogenesis, and Antimicrobial Drug Resistance].Semantic proximity Read ↗

Using genomics to understand antimicrobial resistance and transmission in Neisseria gonorrhoeaeSemantic proximity Read ↗

Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century.Semantic proximity Read ↗

Management and prevention of Neisseria meningitidis and Neisseria gonorrhoeae infections in the context of evolving antimicrobial resistance trendsSemantic proximity Read ↗

Antimicrobial resistance in Neisseria gonorrhoeae and Treponema pallidum: evolution, therapeutic challenges and the need to strengthen global surveillance.Semantic proximity Read ↗

Future Prospects for Neisseria gonorrhoeae TreatmentSemantic proximity Read ↗

Antimicrobial Resistance in Neisseria gonorrhoeae: Proceedings of the STAR Sexually Transmitted Infection-Clinical Trial Group Programmatic Meeting.Semantic proximity Read ↗

Antibiotic resistance in Neisseria gonorrhoeae : origin, evolution, and lessons learned for the futureSemantic proximity Read ↗

Applications of genomics to slow the spread of multidrug‐resistant Neisseria gonorrhoeaeSemantic proximity Read ↗

Azithromycin susceptibility of Neisseria gonorrhoeae in the USA in 2017: a genomic analysis of surveillance dataSemantic proximity Read ↗

Progression of antibiotic resistance in Neisseria meningitidisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.